Study of Pharmacokinetics, Pharmacodynamics, Safety of BCD-131 Compared to Mircera and Aranesp in Healthy Volunteers

NCT02731469 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Reticulocyte Count

Interventions

BIOLOGICAL: BCD-131
BIOLOGICAL: Mircera®
BIOLOGICAL: Aranesp®

Sponsor

Biocad